ATE348880T1 - Hbv mutanten und methoden für deren nachweis - Google Patents

Hbv mutanten und methoden für deren nachweis

Info

Publication number
ATE348880T1
ATE348880T1 AT97934385T AT97934385T ATE348880T1 AT E348880 T1 ATE348880 T1 AT E348880T1 AT 97934385 T AT97934385 T AT 97934385T AT 97934385 T AT97934385 T AT 97934385T AT E348880 T1 ATE348880 T1 AT E348880T1
Authority
AT
Austria
Prior art keywords
viral
present
detection
methods
assays
Prior art date
Application number
AT97934385T
Other languages
German (de)
English (en)
Inventor
Stephen Alister Locarnini
Angeline Ingrid Bartholomeusz
Thein Thein Aye
Man Robert A De
Original Assignee
Melbourne Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melbourne Health filed Critical Melbourne Health
Application granted granted Critical
Publication of ATE348880T1 publication Critical patent/ATE348880T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97934385T 1996-11-08 1997-08-15 Hbv mutanten und methoden für deren nachweis ATE348880T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO3519A AUPO351996A0 (en) 1996-11-08 1996-11-08 Viral variants and methods for detecting same

Publications (1)

Publication Number Publication Date
ATE348880T1 true ATE348880T1 (de) 2007-01-15

Family

ID=3797830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934385T ATE348880T1 (de) 1996-11-08 1997-08-15 Hbv mutanten und methoden für deren nachweis

Country Status (9)

Country Link
US (4) US6555311B1 (enExample)
EP (1) EP0964916B1 (enExample)
JP (4) JP2001503277A (enExample)
AT (1) ATE348880T1 (enExample)
AU (1) AUPO351996A0 (enExample)
CA (1) CA2270178C (enExample)
DE (1) DE69737126T2 (enExample)
ES (1) ES2279542T3 (enExample)
WO (1) WO1998021317A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA973367B (en) * 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AR028149A1 (es) * 1999-07-08 2003-04-30 Innogenetics Nv Deteccion de la resistencia a los farmacos contra la hepatitis b
AUPQ810900A0 (en) 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
SG90149A1 (en) * 2000-07-18 2002-07-23 Government Of The Republic Of Diagnostic assay
US6697858B1 (en) * 2000-08-14 2004-02-24 Telephony@Work Call center
US7405039B2 (en) 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
CN100497604C (zh) * 2002-02-07 2009-06-10 墨尔本保健公司 对核苷类似物具有改变的敏感性的病毒变体及其应用
US8278432B2 (en) 2002-03-29 2012-10-02 Innogenetics N.V. HBV drug resistance methods
EP1499712A4 (en) 2002-04-12 2008-04-16 Melbourne Health HEPATITIS B VIRUS VARIANTS WITH REDUCED SENSITIVITY TO NUCLEOSIDANALOGES AND USE THEREOF
AU2003213874B2 (en) * 2002-04-12 2008-12-04 Austin Health Hepatitis B viral variants with redused susceptibility to nucleoside analogs and uses thereof
CA2486420C (en) 2002-06-14 2014-04-15 Gen-Probe Incorporated Compositions and methods for detecting hepatitis b virus
US20050053916A1 (en) * 2002-10-01 2005-03-10 Korba Brent E. Diagnostic for long term response of HBV carrier to 3TC therapy
ES2494840T3 (es) 2005-03-15 2014-09-16 Fujirebio Europe N.V. Variantes víricas de la hepatitis B con susceptibilidad reducida a análogos de nucleósidos y usos de las mismas
PT1858915E (pt) 2005-03-15 2014-06-11 Justus Liebig Universität Giessen Variantes do vírus de hepatite b resistentes contra alguns análogos de nucleósido, mas sensíveis a outros, e suas utilizações
EP1874923A4 (en) 2005-04-08 2010-08-04 Melbourne Health VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF
US8211443B2 (en) 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
KR100790226B1 (ko) 2005-11-03 2008-01-02 연세대학교 산학협력단 독성 간염 유발 감수성을 검출하는 방법
US12527665B2 (en) 2008-12-11 2026-01-20 Pacific Biosciences Of California, Inc. Methods for identifying modified bases in nucleic acid templates
AU2009325069B2 (en) * 2008-12-11 2015-03-19 Pacific Biosciences Of California, Inc. Classification of nucleic acid templates
US9175338B2 (en) 2008-12-11 2015-11-03 Pacific Biosciences Of California, Inc. Methods for identifying nucleic acid modifications
EP2694686B2 (en) 2011-04-06 2023-07-19 The University of Chicago COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC)
US9238836B2 (en) 2012-03-30 2016-01-19 Pacific Biosciences Of California, Inc. Methods and compositions for sequencing modified nucleic acids
WO2013163207A1 (en) 2012-04-24 2013-10-31 Pacific Biosciences Of California, Inc. Identification of 5-methyl-c in nucleic acid templates
EP4069271A1 (en) * 2019-12-07 2022-10-12 ISA Pharmaceuticals B.V. Treatment of diseases related to hepatitis b virus
US12442821B2 (en) * 2021-07-01 2025-10-14 National Cheng Kung University Kit of in vitro quantifying large surface protein of hepatitis B virus (HBV), biomarker set for analyzing phases of HBV infection and hepatoma prognosis, and set of monoclonal antibodies for predicting, diagnosing or treating chronic liver disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595739A (en) * 1993-05-07 1997-01-21 Abbott Laboratories Hepatitis B virus mutants, reagents and methods for detection
ZA973367B (en) * 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
USRE40233E1 (en) * 1996-11-08 2008-04-08 Melbourne Health Viral variants and methods for detecting same
AUPO351996A0 (en) * 1996-11-08 1996-12-05 Western Health Care Network Viral variants and methods for detecting same
AUPP967999A0 (en) * 1999-04-09 1999-05-06 North Western Health Care Network Viral variants
AUPQ810900A0 (en) * 2000-06-09 2000-07-06 Austin and Repatriation Medical Centre, The Viral variants and methods of using same
US7405039B2 (en) * 2002-02-07 2008-07-29 Austin Health Viral variants with altered susceptibility to nucleoside analogs and uses thereof
US8278432B2 (en) * 2002-03-29 2012-10-02 Innogenetics N.V. HBV drug resistance methods
EP1499712A4 (en) * 2002-04-12 2008-04-16 Melbourne Health HEPATITIS B VIRUS VARIANTS WITH REDUCED SENSITIVITY TO NUCLEOSIDANALOGES AND USE THEREOF
KR101326612B1 (ko) * 2003-10-21 2013-11-12 멜버른 헬스 Ｈｂｖ 변이체 검출 및 응용
PT1858915E (pt) * 2005-03-15 2014-06-11 Justus Liebig Universität Giessen Variantes do vírus de hepatite b resistentes contra alguns análogos de nucleósido, mas sensíveis a outros, e suas utilizações
ES2494840T3 (es) * 2005-03-15 2014-09-16 Fujirebio Europe N.V. Variantes víricas de la hepatitis B con susceptibilidad reducida a análogos de nucleósidos y usos de las mismas
US8211443B2 (en) * 2005-04-08 2012-07-03 Melbourne Health Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof
EP1874923A4 (en) * 2005-04-08 2010-08-04 Melbourne Health VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF
EP2029747A4 (en) * 2006-06-06 2011-01-05 Melbourne Health PROOF AND USE OF ANTIVIRAL RESISTANCE MUTATIONS

Also Published As

Publication number Publication date
WO1998021317A1 (en) 1998-05-22
EP0964916B1 (en) 2006-12-20
US20030124096A1 (en) 2003-07-03
AUPO351996A0 (en) 1996-12-05
ES2279542T3 (es) 2007-08-16
CA2270178A1 (en) 1998-05-22
DE69737126T2 (de) 2007-10-04
US6555311B1 (en) 2003-04-29
JP2001503277A (ja) 2001-03-13
US20100203506A1 (en) 2010-08-12
EP0964916A1 (en) 1999-12-22
HK1027374A1 (en) 2001-01-12
JP2008154590A (ja) 2008-07-10
EP0964916A4 (en) 2001-09-26
US20130171620A1 (en) 2013-07-04
JP2012055322A (ja) 2012-03-22
JP2015107127A (ja) 2015-06-11
CA2270178C (en) 2012-06-12
DE69737126D1 (de) 2007-02-01

Similar Documents

Publication Publication Date Title
DE69737126D1 (de) Hbv mutanten und methoden für deren nachweis
DE69022578D1 (de) Test für Hepatitis-C.
PL311653A1 (en) Novel methods of classifying c-type hepatitis viruses and reagents for use in such methods
EP2360257A3 (en) Hepatitis B virus (HBV) variants
EP2319917A3 (en) Viral variants with altered susceptibility to nucleoside analogs and uses thereof
CA2077764A1 (en) Antibody to pacap and use thereof
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
DE69432043D1 (de) Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
EP2404933A3 (en) HBV variants detection and application
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
EP1297109A4 (en) HEPATITIS B VIRUS DNA POLYMERASE AND SURFACE ANTIGEN VARIATIONS AND METHODS OF ITS USE
AU636964B2 (en) Immunological detection of metolachlor
CA2303123A1 (en) Method for detecting antibodies in a sample
FI913611A7 (fi) Menetelmä elohopean toteamiseksi elohopeasta aiheutuneen kohonneen bio luminesenssin omaavien mikro-organismien avulla
FI881355A7 (fi) Määritysmenetelmä hepatiittiantigeenien ja AIDS-vasta-aineiden toteamiseksi.
DE59811247D1 (de) Nachweis von adenosin in kleinen proben
IL77862A (en) Enzymatic immunoassay to determine the amount of antibodies to htlv-iii and test kit
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
ATE154395T1 (de) Monoklonale antikörper
PT974055E (pt) Metodo de titulacao de uma composicao viral complexa
ATE133266T1 (de) Nachweis von viralen oder bakteriellen antigenen mittels durchflusscytometrie
ATE269971T1 (de) Verfahren zur prüfung von immunokompetenz
GR3022299T3 (en) Immunological detection of triasulfuron

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0964916

Country of ref document: EP